Clinical trials - Press Releases

Date	Title	Company
15-Dec-2020	ABPI Board announces Kate Brunner QC appointed as new Chair of the PMCPA Appeal Board	ABPI
15-Dec-2020	Sensyne Health launches first digital health product in the U.S.	Sensyne Health
15-Dec-2020	Minoryx’s clinical candidate leriglitazone shows clinical benefit in a proof of concept Phase 2 study in Friedreich´s ataxia	Minoryx
15-Dec-2020	CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes	Sanofi
15-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
15-Dec-2020	Primary care committed to Covid vaccine programme but needs support	NHS Confederation
15-Dec-2020	Polyphor announces third positive Data Safety Monitoring Board (DSMB) recommendation to continue Phase III balixafortide FORTRESS study without modifications	Polyphor AG
15-Dec-2020	The number of Russians ready to be vaccinated against coronavirus has reached 42%, a FOM poll shows	Russian Direct Investment Fund (RDIF)
15-Dec-2020	Janssen Receives Positive CHMP Opinion for SPRAVATO®▼ (Esketamine Nasal Spray) for the Rapid Reduction of Depressive Symptoms in a Psychiatric Emergency for Patients with Major Depressive Disorder	Janssen Pharmaceutical Companies of Johnson & Johnson
15-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
15-Dec-2020	PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization	Carterra, Inc
15-Dec-2020	True Medical Partners with Trulioo to Provide Real-Time Identity Verification During Digital Onboarding and Meet Regulatory Compliance	Trulioo
15-Dec-2020	Imfinzi recommended for approval in the EU by CHMP for less-frequent, fixed-dose use in unresectable non-small cell lung cancer	AstraZeneca
15-Dec-2020	Sanofi renews partnership with the WHO to fight Neglected Tropical Diseases and eliminate sleeping sickness before 2030	Sanofi
14-Dec-2020	CHMP recommends approval of Plavix® (clopidogrel) with aspirin in adults for certain types of strokes	Sanofi
14-Dec-2020	BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma	Merck and Pfizer
14-Dec-2020	TYK2 Identified as a Key Genetic Mechanism of Critical Illness in Covid-19 and as an Important Potential Target for Therapy	SAREUM HOLDINGS PLC
14-Dec-2020	ViiV Healthcare announces positive CHMP opinion for Rukobia (fostemsavir), a first-in-class attachment inhibitor for the treatment of adults with multidrug-resistant HIV with few treatment options available	ViiV Healthcare
14-Dec-2020	OncoZenge raises MSEK 10 ahead of spin-off and separate listing	Moberg Pharma
14-Dec-2020	Atox Bio announces FDA acceptance of New Drug Application	Arix Bioscience plc